CRISIL Limited (BOM:500092)
India · Delayed Price · Currency is INR 4,538.15
-6.20 (-0.14%)
At close: Jan 22, 2026
CRISIL Revenue
CRISIL had revenue of 9.11B INR in the quarter ending September 30, 2025, with 12.24% growth. This brings the company's revenue in the last twelve months to 34.80B, up 6.61% year-over-year. In the year 2024, CRISIL had annual revenue of 32.60B with 3.83% growth.
Revenue (ttm)
34.80B
Revenue Growth
+6.61%
P/S Ratio
9.44
Revenue / Employee
7.46M
Employees
4,666
Market Cap
328.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 32.60B | 1.20B | 3.83% |
| Dec 31, 2023 | 31.40B | 3.71B | 13.39% |
| Dec 31, 2022 | 27.69B | 4.68B | 20.34% |
| Dec 31, 2021 | 23.01B | 3.19B | 16.09% |
| Dec 31, 2020 | 19.82B | 2.50B | 14.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Godrej Industries | 225.81B |
| NLC India | 162.51B |
| Blue Star | 122.31B |
| KEI Industries | 107.04B |
| United Breweries | 92.40B |
| Godfrey Phillips India | 59.37B |
| 3M India | 47.51B |
| Procter & Gamble Hygiene and Health Care | 43.26B |
CRISIL News
- 7 weeks ago - Crisil features in Chartis RiskTech100 2026 for third successive year - Business Upturn
- 4 months ago - CRISIL shares jump over 2% after announcing $38 million acquisition of McKinsey’s PriceMetrix - Business Upturn
- 6 months ago - CRISIL board declares second interim dividend of Rs 9 per share - Business Upturn
- 6 months ago - Crisil Q1 Results: Revenue up 5.7% YoY to Rs 843 crore, Net Profit up 14% YoY - Business Upturn
- 9 months ago - CRISIL Q4 FY25 Results: Net profit rises 16% YoY to ₹159.8 crore, Margin expands to 28.5% - Business Upturn
- 1 year ago - Crisil shares drop over 8% as Q3 revenue declines - Business Upturn
- 1 year ago - Crisil Q3 Results: Revenue down 0.5% to Rs 912.91 crore, Net Profit up 7.03% YoY - Business Upturn
- 1 year ago - Top gainers today: Piramal Pharma surges 5.85%, CRISIL rises 3.63%, Aditya Birla Capital gains 2.76%, AstraZeneca Pharma up 2.57% - Business Upturn